An opioid treatment clinic in VermontJordan Silverman/Getty
Early in August, the US Food and Drug Administration (FDA) approved a sixth medication for reversing opioid overdoses. The product, call Zurnai, is an automatic injection of the drug nalmefene, produced by Purdue Pharma – the same pharmaceutical company that helped fuel the opioid crisis.
Irony aside, this is – at least at face value – a welcome addition to the growing arsenal of medications meant to combat the opioid crisis. Nalmefene is stronger and has a longer duration than its more common counterpart naloxone, which has become less effective against an…
We have tools to solve the opioid crisis – so why aren’t they used?
Related Posts
Vermont caps emergency motel housing for homeless, forcing many to leave this month
BERLIN, Vt. — This fall, hundreds of the most vulnerable people experiencing homelessness in Vermont must leave state-funded motel rooms where they’ve been living as the state winds down its…
Lessons from COVID-19 position world better against mpox: vaccine alliance
A Bavarian Nordic research team member holding a test tube. — Reuters/FileLessons learned from the COVID-19 pandemic have left the world in a much better position to tackle the current…